A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Clinical trial NCT05160168 · TERMINATED

Trial details

NCT number: NCT05160168
Sponsor: Theseus Pharmaceuticals
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors (GIST)Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue Neoplasms by Histologic Type Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasm Digestive System Disease Gastrointestinal Diseases

Start date: 2022-01-03
Primary completion: 2024-02-02
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.